Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Events / Technology / Medical Care Technologies withdraws AI patent
Tech patent withdrawal

Medical Care Technologies withdraws AI patent

Analysis based on 6 articles · First reported Jul 02, 2026 · Last updated Jul 02, 2026

Sentiment
40
Attention
3
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market may view Medical Care Technologies Inc.'s decision positively, as it signals rapid innovation and a commitment to cutting-edge technology, potentially leading to increased investor confidence in Medical Care Technologies Inc.'s future products and market position. This could result in a slight increase in the stock price of Medical Care Technologies Inc. due to perceived technological leadership.

Technology Healthcare
Event Summary

Medical Care Technologies Inc. announced its decision to withdraw U.S. Provisional Patent Application No. 63/854,935, originally filed in July 2025 for its AI Vision Technology. This move reflects the company's accelerated pace of innovation, as its current proprietary AI vision systems and software have advanced significantly beyond the scope of the initial application. Marshall Perkins, CEO of Medical Care Technologies Inc., stated that the company is now focused on deploying and protecting its next-generation solutions, which are already powering real-world products. Key implementations of Medical Care Technologies Inc.'s evolved AI Vision technology include Vision API Services, the MDCE Melanoma Scan Beta platform, and advanced image recognition features integrated into Snapshot Recipes and RealGameUsed.com authentication workflows.

Key Actions
90 Medical Care Technologies Inc. withdrew patent application
Entities Involved
priv
Medical Care Technologies Inc.
Medical Care Technologies Inc. decided not to proceed with its U.S. Provisional Patent Application No. 63/854,935 because its AI vision technology has advanced significantly beyond the original application, demonstrating rapid innovation and a focus on next-generation solutions.
Importance 100.0 Sentiment 50.0
per
Marshall Perkins
Marshall Perkins, CEO of Medical Care Technologies Inc., commented on the rapid progress of the company's AI vision technology, emphasizing the focus on deploying and protecting next-generation solutions.
Importance 60.0 Sentiment 40.0
Relationships
Medical Care Technologies Inc. related ↔ Marshall Perkins
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.